Immunotherapy Enhances Effectiveness of KRAS-Targeted Treatments in Pancreatic Cancer
In a groundbreaking study that has the potential to reshape the treatment landscape for pancreatic cancer, researchers from the Perelman School of Medicine at the University of Pennsylvania have demonstrated that the addition of immunotherapy to a novel …